‘Too Good to Be True’: A Chinese Study on Timing Cancer Therapy Is Retracted

‘Too Good to Be True’: A Chinese Study on Timing Cancer Therapy Is Retracted The New York Times Retraction of high-profile paper on cancer drug timing could hand ammo to China hawks Endpoints News Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing Fierce Pharma Four months after the announcement, a Chinese research team paper containing that the time zone for 매일경제 Discussions Around Retraction of Debated Study on Early Morning Immunotherapy Benefits Oncodaily